|Bid||85.11 x 900|
|Ask||86.46 x 900|
|Day's range||85.51 - 86.82|
|52-week range||73.12 - 88.91|
|Beta (5Y monthly)||0.64|
|PE ratio (TTM)||36.31|
|Forward dividend & yield||1.12 (1.30%)|
|Ex-dividend date||02 Dec 2021|
|1y target est||N/A|
WASHINGTON & DEERFIELD, Ill., January 13, 2022--The Thurgood Marshall College Fund (TMCF), the largest organization exclusively representing the Black College community, and the Baxter International Foundation, the philanthropic arm of Baxter International Inc. (NYSE:BAX), introduced today a new collaboration called the Baxter HBCU STEM Scholars Program. The three-year, $3.5 million initiative funds scholarships and mentoring as part of a multi-faceted approach to support students at Historicall
DEERFIELD, Ill., January 06, 2022--Baxter International Inc. (NYSE:BAX), a global medtech leader, will host a conference call to discuss its fourth-quarter 2021 financial results on Thursday, February 17, 2022 at 7:30 a.m. Central Time. To participate in this conference call please follow this link http://www.directeventreg.com/registration/event/3168996 to pre-register for the call and receive the call information.
DEERFIELD, Ill., December 13, 2021--Baxter International Inc. (NYSE:BAX), a global medtech leader, announced today it has completed its acquisition of Hillrom. Baxter paid $156.00 in cash for each outstanding share of Hillrom common stock for a purchase price of $10.5 billion (based on Hillrom share counts at closing). Including the assumption of Hillrom’s outstanding debt obligations, the enterprise value of the transaction is approximately $12.5 billion.